Abstract

Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension

Author(s): Helms Scott R, Fox Samantha, Mixon William, Vail Jane

Issue: Jan/Feb 2012 - Volume 16, Number 1

Page(s): 34-41

Download in electronic PDF format for $75
  • Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension Page 1
  • Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension Page 2
  • Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension Page 3
  • Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension Page 4
  • Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension Page 5
  • Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension Page 6
  • Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension Page 7
  • Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension Page 8

Abstract

Pimobendan (Vetmedin) is an effective treatment for canine chronic degenerative mitral valve disease and dilated cardiomyopathy. In an off-label use, it may also be of benefit for the treatment of pulmonary hypertension in dogs. In this report, we describe the effects of a palatable customized oral form of pimobendan used with both compounded and commercially manufactured conventional drug therapy to treat degenerative mitral valve disease and pulmonary hypertension in two small dogs. For those patients, who resisted many types of oral medication, the standard manufactured dose of pimobendan was inappropriate. Formulations of the preparations used to treat the patients described in this report are provided for easy reference. It should be noted that at the time of this writing, Boehringer Ingelheim GmbH (Ingelheim am Rhein, Germany), the manufacturer of pimobendan, has expressed concern about the stability of that agent in aqueous compounded form. To our knowledge, no current data confirming the stability or bioequivalence of compounded pimobendan exist.

Related Keywords

  • Jane Vail
  • canine chronic degenerative mitral valve disease
  • dilated cardiomyopathy
  • dogs
  • phosphodiesterase 3 inhibitor
  • pimobendan
  • case reports
  • enalapril
  • sildenafil citrate
  • formulations
  • furosemide

Related Categories

  • FORMULATIONS
  • VETERINARY
  • CASE REPORTS
  • CARDIOLOGY
  • INFORMATION RESOURCES

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2012
Pg. 34-41
Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension
Author(s): Helms Scott R, Fox Samantha, Mixon William, Vail Jane
May/Jun 2003
Pg. 188-191
Treating Canine Hepatic Disease
Author(s): Davidson Gigi S
Jul/Aug 2003
Pg. 288-291
Basics of Compounding for Raynaud's Disease
Author(s): Glasnapp Andrew
Jan/Feb 2013
Pg. 24-27
Treatment of Canine Pulmonary Hypertension: Is Tadalafil an Appropriate Alternative to Sildenafil?
Author(s): Wung Deanna
Nov/Dec 2006
Pg. 421-424
Taurine for the Treatment of Canine Dilated Cardiomyopathy
Author(s): Vail Jane
Jul/Aug 1997
Pg. 242-243
Case Reports: Osteomyelitis in a Young Draft Horse; Quarter Horse Gelding with Chronic Obstructive Pulmonary Disease
Author(s): Patterson Donna, Ford Peter R, Gallon Marlene D
Nov/Dec 2006
Pg. 405-408
Application of Sildenafil for Pulmonary Hypertension in Canines and Foals
Author(s): Davidson Gigi S
Jan/Feb 2012
Pg. 12-16
Glutaraldehyde-treated Autologous Pericardium Used in Valve Repairs
Author(s): McElhiney Linda F
Jan/Feb 2011
Pg. 27-31
Goliath: Case Report on a Canine Case of Epilepsy
Author(s): Ameijeiras Carlos, Ray Jody, Jordan Dinah G, Garcia Abby Furr
Sep/Oct 2010
Pg. 382-394
Conservative Management of Chronic Kidney Disease in Cats: Recommendations for Veterinarians and Compounding Pharmacists
Author(s): Meadows Richard L, Muller George
Mar/Apr 2011
Pg. 114-116
Case Report: Clindamycin Hydrochloride 1% Otic Suspension in the Management of Otitis Externa in a Canine
Author(s): Rudner Shara, Pora Amanda, DeMeo Jennifer
May/Jun 2002
Pg. 210-215
The Treatment of Canine Atopic Disease
Author(s): Davidson Gigi S
Sep/Oct 2008
Pg. 384-390
Canine Public Servants: Caring for Drug Detection Dogs
Author(s): Davidson Gigi S
Sep/Oct 2012
Pg. 364-368
Compounded Oral Ketamine for Severe Depression, Anxiety, and Pain in a Hospice Patient with End-stage Chronic Obstructive Pulmonary Disease, Cardiopulmonary Failure, and Severe Renal Insufficiency: A Case Report
Author(s): McNulty Jack P, Hahn Kristian
Mar/Apr 2011
Pg. 124-128
Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease
Author(s): Corsini Lindsay, Williams LaVonn A
Nov/Dec 2010
Pg. 488-491
Case Report: Management of Secondary Hypertension in a Feline with the Use of Transdermal Prazosin
Author(s): Rudner Shara, Browne Paul
Jan/Feb 2010
Pg. 40-45
Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis
Author(s): Muller George, Young Thomas W, Reina Rachel, Caldwell Delmar R
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Mar/Apr 2001
Pg. 92-94
Feline Ophthalmic Disease: Feline Herpesvirus and Systemic Hypertension
Author(s): Davidson Michael G
Jul/Aug 2022
Pg. 293-296
Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases
Author(s): Harrington Amy, Williams LaVonn